Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00888901Phase 4Completed
A Phase 4 trial of eltrombopag in Chronic Immune Thrombocytopenia (cITP), sponsored by Ingrid Pabinger. Started May 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00888901.